LANIRAPID Side Effects

6299643-2 | Liver Disorder, Pancytopenia, Pyrexia, Thrombocytopenia
on Jul 29, 2009 Male patient from JAPAN , weighting 121.3 lb, was diagnosed with supraventricular tachycardia, hypertension, gastritis, angina pectoris, percutaneous coronary intervention and was treated with Lanirapid (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder, pancytopenia, pyrexia, thrombocytopenia. Lanirapid dosage: . During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), NORVASC (View Norvasc Review and Norvasc Label ), ADALAT CC (View Adalat Cc Review and Adalat Cc Label ), OMEPRAL (View Omepral Review and Omepral Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), FLUITRAN (View Fluitran Review and Fluitran Label ).

5359631-7 | Arterial Thrombosis Limb, Embolism
Patient was taking Lanirapid (View Usage). Patient had the following side effects: arterial thrombosis limb, embolism on Jun 05, 2007 from JAPAN Additional patient health information: Female patient , 65 years of age, was diagnosed with ventricular fibrillation and. Lanirapid dosage: .05 Mg, 1x/day. During the same period patient was treated with ACARDI (2.5 Mg, 1x/day) (View Acardi Review and Acardi Label ), LASIX (60 Mg, 1x/day) (View Lasix Review and Lasix Label ), ALDACTONE (75 Mg, 1x/day) (View Aldactone Review and Aldactone Label ), WARFARIN POTASSIUM (1 Mg, 1x/day) (View Warfarin Potassium Review and Warfarin Potassium Label ), METOPROLOL TARTRATE (5 Mg, 1x/day) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ).

5344328-X | Arterial Thrombosis Limb, Embolism
Adverse event was reported on May 22, 2007 by a Female patient taking Lanirapid (View Usage) (Dosage: .05 Mg, 1x/day) was diagnosed with ventricular fibrillation and. Location: JAPAN , 65 years of age, After Lanirapid was administered, patient had the following side effects: arterial thrombosis limb, embolism. During the same period patient was treated with ACARDI (2.5 Mg, 1x/day) (View Acardi Review and Acardi Label ), LASIX (60 Mg, 1x/day) (View Lasix Review and Lasix Label ), ALDACTONE (75 Mg, 1x/day) (View Aldactone Review and Aldactone Label ), WARFARIN POTASSIUM (1 Mg, 1x/day) (View Warfarin Potassium Review and Warfarin Potassium Label ), METOPROLOL TARTRATE (5 Mg, 1x/day) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ).

4968137-6 | Atrial Fibrillation
on Mar 29, 2006 Male patient from JAPAN , 80 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?), prophylaxis, hypertension and was treated with Lanirapid (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?). Lanirapid dosage: 0.1 Mg, Unk. During the same period patient was treated with ASPIRIN (100 Mg, Unk) (View Aspirin Review and Aspirin Label ), DICHLOTRIDE (View Dichlotride Review and Dichlotride Label ), ASPENON (40 Mg, Unk) (View Aspenon Review and Aspenon Label ), ADALAT (40 Mg, Unk) (View Adalat Review and Adalat Label ), CARDENALIN (2 Mg, Unk) (View Cardenalin Review and Cardenalin Label ), DIOVAN (80 Mg, Qd) (View Diovan Review and Diovan Label ).